Clinical Trial Update: Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing antiplatelet therapy in acute mild-to-moderate ischemic stroke has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED